Singular Genomics Systems Inc (OMIC)
21.78
-0.12
(-0.57%)
USD |
NASDAQ |
Nov 22, 11:12
Singular Genomics Systems Debt to Equity Ratio: 0.0419 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0419 |
| June 30, 2024 | 0.0461 |
| March 31, 2024 | 0.0487 |
| December 31, 2023 | 0.0497 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0511 |
| June 30, 2023 | 0.0464 |
| March 31, 2023 | 0.042 |
| December 31, 2022 | 0.0387 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0387
Minimum
Dec 2022
0.0511
Maximum
Sep 2023
0.0456
Average
0.0462
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5796 |
| Bionano Genomics Inc | 0.306 |
| Akoya Biosciences Inc | 5.568 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 186.55M |
| Total Liabilities (Quarterly) | 63.30M |
| Shareholders Equity (Quarterly) | 123.25M |
| Current Ratio | 7.372 |
| Net Debt Paydown Yield | 2.53% |